Assessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay

Crosstalk in NF-κB signaling pathways

(2011) Andrea Oeckinghaus et al.   NATURE IMMUNOLOGY

Epstein-Barr virus promotes interferon-α production by plasmacytoid dendritic cells

(2010) Timothy E. Quan et al.   ARTHRITIS AND RHEUMATISM

Co-stimulation with TLR7/8 and TLR9 agonists induce down-regulation of innate immune responses in sheep blood mononuclear and B cells

(2010) Jayaum S. Booth et al.   DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY

Toll-Like Receptor Agonists Synergistically Increase Proliferation and Activation of B Cells by Epstein-Barr Virus

(2010) S. Iskra et al.   JOURNAL OF VIROLOGY

Epstein Barr virus inhibits the stimulatory effect of TLR7/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes

(2010) Vahid Younesi et al.   MICROBIOLOGY AND IMMUNOLOGY

Toll-like receptors - sentries in the B-cell response

(2009) Isabelle Bekeredjian-Ding et al.   IMMUNOLOGY

Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines

(2008) C. L. Ahonen et al.   BLOOD

Paired Toll-like Receptor Agonists Enhance Vaccine Therapy through Induction of Interleukin-12

(2008) R. Zheng et al.   CANCER RESEARCH

Human plasma accelerates immortalization of B lymphocytes by Epstein–Barr virus

(2008) E. Manor   CELL PROLIFERATION

Fc receptor-like 1-5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia

(2008) Tohid Kazemi et al.   INTERNATIONAL JOURNAL OF CANCER

Signaling through Toll-Like Receptors Induces Murine Gammaherpesvirus 68 Reactivation In Vivo

(2008) L. M. Gargano et al.   JOURNAL OF VIROLOGY

The interplay between viruses and innate immune signaling: Recent insights and therapeutic opportunities

(2007) Leonie Unterholzner et al.   BIOCHEMICAL PHARMACOLOGY